Clinical Trial Update: the Efficacy and Safety of Agomelatine in the Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of agomelatine in patients with Parkinson's disease and depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Parkinson Disease

Drugs mentioned

• Agomelatine (agomelatine)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Parkinson Disease, Depression | Phase 4 | Status: UNKNOWN